Published in Clin J Am Soc Nephrol on May 07, 2008
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation. Transplantation (2011) 1.51
Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol (2011) 1.02
Hemoglobin variability after renal transplantation is associated with mortality. Transpl Int (2012) 0.91
Does posttransplant anemia at 6 months affect long-term outcome of live-donor kidney transplantation? A single-center experience. Clin Exp Nephrol (2009) 0.81
Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol (2011) 0.79
Blood disorders typically associated with renal transplantation. Front Cell Dev Biol (2015) 0.77
Assessment of the use of LED phototherapy on bone defects grafted with hydroxyapatite on rats with iron-deficiency anemia and nonanemic: a Raman spectroscopy analysis. Lasers Med Sci (2014) 0.77
ESAs in transplant anemia: one size does not "fit all". J Am Soc Nephrol (2012) 0.77
Anemia control in kidney transplant recipients using once-monthly continuous erythropoietin receptor activator: a prospective, observational study. J Transplant (2014) 0.75
Association of hepcidin-25 with survival after kidney transplantation. Eur J Clin Invest (2016) 0.75
Erythropoiesis stimulating agents and reno-protection: a meta-analysis. BMC Nephrol (2017) 0.75
Clinical profile and post-transplant anaemia in renal transplant recipients restarting dialysis after a failed graft: changing trends between 2001 and 2009. Clin Kidney J (2013) 0.75
The efficacy of the use of IR laser phototherapy (LPT) on bone defect grafted with biphasic ceramic on rats with iron deficiency anemia: Raman spectroscopy analysis. Lasers Med Sci (2014) 0.75
Anemia and low-grade inflammation in pediatric kidney transplant recipients. Pediatr Nephrol (2016) 0.75
Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med (2006) 17.55
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med (2006) 10.65
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol (2005) 4.35
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis (2007) 3.96
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 3.37
Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int (2004) 2.30
Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant (2003) 2.21
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Anemia is associated with mortality in kidney-transplanted patients--a prospective cohort study. Am J Transplant (2007) 1.84
Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol (2006) 1.57
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int (2004) 1.48
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol (2006) 1.43
Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant (2004) 1.30
Hypoxia-induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol (1999) 1.19
Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol (2003) 1.16
Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol (2002) 1.13
Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol (2004) 1.07
Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation (2006) 1.03
Anemia after renal transplantation. Am J Kidney Dis (2006) 1.01
Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant (2002) 0.96
Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant (2004) 0.88
Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome. Nat Clin Pract Cardiovasc Med (2005) 0.85
Serum erythropoietin levels in the immediate kidney-posttransplant period. Nephron (1992) 0.81
Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant (2002) 0.81
Erythropoietin and erythropoiesis in renal transplantation. Nephrol Dial Transplant (1995) 0.80
Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol (2006) 4.10
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation (2008) 2.62
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA (2013) 2.29
MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med (2012) 2.20
Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging (2008) 2.03
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation (2003) 1.99
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol (2006) 1.97
LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging (2011) 1.96
A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol (2011) 1.94
Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol (2011) 1.89
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology (2012) 1.56
Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl (2014) 1.50
Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation (2013) 1.50
Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging (2009) 1.48
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol (2008) 1.41
Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging (2011) 1.32
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol (2006) 1.25
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest (2014) 1.24
Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol (2013) 1.20
The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. Transplantation (2014) 1.15
Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol (2003) 1.13
The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg (2010) 1.11
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg (2011) 1.11
Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med (2012) 1.10
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08
Direct en face imaging of secundum atrial septal defects by velocity-encoded cardiovascular magnetic resonance in patients evaluated for possible transcatheter closure. Circ Cardiovasc Imaging (2008) 1.08
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Transplantation (2009) 1.06
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol (2010) 1.04
A review of quality of life instruments used in liver transplantation. J Hepatol (2009) 1.03
Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation (2015) 0.96
Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int (2012) 0.94
Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation (2011) 0.93
Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol (2014) 0.92
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats. Transplantation (2011) 0.91
Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation (2011) 0.90
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest (2014) 0.89
Isolation and enrichment of murine spermatogonial stem cells using rhodamine 123 mitochondrial dye. Biol Reprod (2004) 0.89
Program-specific reports: implications and impact on program behavior. Curr Opin Organ Transplant (2013) 0.89
Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transpl (2012) 0.88
Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research. Curr Opin Organ Transplant (2012) 0.87
Role of beta3 integrin in acute renal allograft rejection in humans. Clin J Am Soc Nephrol (2007) 0.86
Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol (2012) 0.85
MicroRNAs as potential therapeutic targets in kidney disease. J Formos Med Assoc (2013) 0.82
High early cardiovascular mortality after liver transplantation. Liver Transpl (2014) 0.82
Induction immunosuppressive therapies in renal transplantation. Am J Health Syst Pharm (2011) 0.82
Are all readmissions the same? Liver Transpl (2012) 0.81
Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol (2012) 0.81
Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown) (2011) 0.79
A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution. Clin Transplant (2010) 0.79
Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1β secretion in the peripheral blood. Transplantation (2014) 0.79
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. Transplantation (2006) 0.79
Comparison of exercise electrocardiography and stress perfusion CMR for the detection of coronary artery disease in women. J Cardiovasc Magn Reson (2012) 0.79
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection. Ther Clin Risk Manag (2009) 0.78
Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal. Pharmacotherapy (2011) 0.78
Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Transplantation (2015) 0.78
NUTORC-a transdisciplinary health services and outcomes research team in transplantation. Transl Behav Med (2012) 0.78
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis (2011) 0.78
HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl (2013) 0.78
The aorta wall of patients presenting to the emergency department with acute myocardial infarction by cardiac magnetic resonance. Atherosclerosis (2010) 0.77
Development of BK nephropathy in recipients of simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.76
Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia. Ann Intern Med (2006) 0.76
Emerging Ethical Considerations of Donation After Circulatory Death: Getting to the Heart of the Matter. Ann Surg (2016) 0.75
Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain. Radiology (2013) 0.75
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients. Int J Nephrol Renovasc Dis (2010) 0.75
T-cell-depleting agents in kidney transplantation: is there a place for alemtuzumab? Am J Kidney Dis (2011) 0.75
Donation after cardiac death liver transplantation: another fly in the ointment. Liver Transpl (2013) 0.75
Chimerism and tolerance induction in kidney transplantation. Nephron (2014) 0.75
Comparative effectiveness research in liver transplantation: crossing the cost and quality chasm. J Comp Eff Res (2013) 0.75
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Early use of renal-sparing agents in liver transplantation: a closer look. Liver Transpl (2013) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients. Clin Transplant (2009) 0.75